Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)
Public ClinicalTrials.gov record NCT01307423. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis Who Have Not Been Previously Treated With Disease-modifying Antirheumatic Drugs
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether apremilast is safe and effective in the treatment of patients with psoriatic arthritis who have not been previously treated with DMARDs. Apremilast is proposed to improve signs and symptoms of psoriatic arthritis (tender and swollen joints, pain, physical function) in treated patients.
Study identification
- NCT ID
- NCT01307423
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 529 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 9, 2010 (Actual)
- Primary completion
- Feb 21, 2013 (Actual)
- Completion
- Aug 16, 2017 (Actual)
- Last update posted
- Jun 14, 2022
2010 – 2017
United States locations
- U.S. sites
- 30
- U.S. states
- 16
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Research Center | Phoenix | Arizona | 85023 | — |
| Desert Medical Advances | Palm Desert | California | 92260 | — |
| In Vivo Clinical Research | Doral | Florida | 33166 | — |
| Centre For Rheumatology, Immun. And Arthritis | Fort Lauderdale | Florida | 33334 | — |
| North Florida Dermatology | Jacksonville | Florida | 32204 | — |
| Florida Center for Dermatology, PA | Saint Augustine | Florida | 32086 | — |
| Tampa Medical Group Pa | Tampa | Florida | 33614 | — |
| Atlanta Dermatology, Vein and Research Center, PC | Alpharetta | Georgia | 30022 | — |
| Arthritis and Rheumatology of Georgia | Atlanta | Georgia | 30342 | — |
| Sonora Clinical Research, LLC | Boise | Idaho | 83702 | — |
| Rockford Orthopedic Associates, LLC | Rockford | Illinois | 61107 | — |
| The Arthritis Center | Springfield | Illinois | 62704 | — |
| Indiana. University | Indianapolis | Indiana | 46202 | — |
| Klein and Associates MD, PA | Cumberland | Maryland | 21502 | — |
| Klein and Associates MD, PA | Hagerstown | Maryland | 21740 | — |
| Clinical Pharmacology Study Group | Worcester | Massachusetts | 01605 | — |
| Justus Fiechtner MD PC | Lansing | Michigan | 48910 | — |
| Heartland Clinical Research, Inc. | Omaha | Nebraska | 68134 | — |
| Physicians East | Greenville | North Carolina | 27834 | — |
| Unifour Medical Research Associatets LLC | Hickory | North Carolina | 28602 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Clinical Research Center of Reading, LLP | West Reading | Pennsylvania | 19610 | — |
| West Tennessee Research Institute | Jackson | Tennessee | 38305 | — |
| Austin Regional Clinic | Austin | Texas | 78731 | — |
| Center for Clinical Studies | Houston | Texas | 77065 | — |
| Houston Medical Research | Houston | Texas | 77090 | — |
| Luckster Enterprises | San Antonio | Texas | 78232 | — |
| Center for Clinical Studies | Webster | Texas | 77598 | — |
| Rheumatology and Immunotherapy Center | Franklin | Wisconsin | 53132 | — |
| PharmaSeek | Middleton | Wisconsin | 53562 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 88 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01307423, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 14, 2022 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01307423 live on ClinicalTrials.gov.